Safety, Pharmacodynamic, and Pharmacokinetic Profile of TSR-042, an Anti–pd–1 Monoclonal Antibody, in Patients (pts) with Advanced Solid Tumors
Annals of Oncology(2017)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined